Capricor Therapeutics, Inc. (CAPR)
32.11
+1.99
(+6.61%)
USD |
NASDAQ |
Apr 02, 16:00
31.50
-0.61
(-1.90%)
After-Hours: 20:00
Capricor Therapeutics Total Liabilities (Quarterly) : 54.15M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 51.59M |
| Vaxart, Inc. | 102.67M |
| Allogene Therapeutics, Inc. | 123.36M |
| REGENXBIO, Inc. | 350.30M |
| Replimune Group, Inc. | 123.05M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 359.95M |
| Shareholders Equity (Quarterly) | 305.79M |
| Debt to Equity Ratio | 0.0587 |
| Current Ratio | 9.011 |
| Net Debt Paydown Yield | -0.16% |